ArticleMolecular oncology2017

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.

Matthias Kolberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.